Total Payments
$1,665
2024 Payments
$705.40
Companies
21
Transactions
106
Medicare Patients
16,333
Medicare Billing
$772,694
Payment Breakdown by Category
Food & Beverage$1,655 (99.4%)
Education$9.24 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,655 | 103 | 99.4% |
| Education | $9.24 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $247.07 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $238.63 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $198.29 | 12 | $0 (2024) |
| Amgen Inc. | $167.94 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $126.84 | 3 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $112.65 | 6 | $0 (2024) |
| Travere Therapeutics, Inc. | $93.04 | 8 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $79.95 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $72.69 | 3 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $62.66 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $705.40 | 53 | OPKO Pharmaceuticals, LLC ($171.65) |
| 2023 | $472.03 | 25 | GlaxoSmithKline, LLC. ($108.78) |
| 2022 | $487.13 | 28 | Amgen Inc. ($101.90) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 11/25/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $1.43 | General |
| Category: NEPHROLOGY | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Cardio-renal | ||||||
| 10/24/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: NEPHROLOGY | ||||||
| 10/24/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: NEPHROLOGY | ||||||
| 10/23/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: NEPHROLOGY | ||||||
| 10/10/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Nephrology | ||||||
| 10/09/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: NEPHROLOGY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.22 | General |
| 09/18/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: NEPHROLOGY | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: NEPHROLOGY | ||||||
| 08/27/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: NEPHROLOGY | ||||||
| 08/26/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: NEPHROLOGY | ||||||
| 08/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 7,619 | 14,326 | $2.8M | $382,454 |
| 2022 | 44 | 7,002 | 11,413 | $1.2M | $323,325 |
| 2021 | 26 | 1,712 | 2,493 | $252,243 | $66,916 |
Total Patients
16,333
Total Services
28,232
Medicare Billing
$772,694
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 45 | 325 | $636,870 | $86,158 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 584 | 746 | $523,737 | $63,488 | 12.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 194 | 503 | $332,614 | $44,879 | 13.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 381 | 467 | $115,667 | $18,853 | 16.3% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 35 | 3,340 | $165,330 | $18,740 | 11.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 91 | 358 | $123,102 | $16,363 | 13.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 124 | 128 | $123,387 | $15,877 | 12.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 92 | 352 | $93,350 | $12,574 | 13.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 353 | 420 | $74,592 | $12,105 | 16.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 81 | 317 | $82,965 | $11,106 | 13.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 101 | 153 | $67,234 | $9,063 | 13.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 39 | $63,433 | $8,513 | 13.4% |
| 82610 | Cystatin c (enzyme inhibitor) level | Office | 2023 | 332 | 415 | $46,115 | $7,499 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $57,554 | $6,373 | 11.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 570 | 787 | $36,690 | $5,949 | 16.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 540 | 663 | $11,934 | $5,548 | 46.5% |
| 80069 | Kidney function blood test panel | Office | 2023 | 436 | 632 | $32,915 | $5,355 | 16.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 277 | 277 | $27,789 | $4,704 | 16.9% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 566 | 779 | $23,513 | $4,379 | 18.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 56 | 130 | $28,252 | $3,872 | 13.7% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 554 | 751 | $23,341 | $3,788 | 16.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 224 | 233 | $14,763 | $2,393 | 16.2% |
| 83735 | Magnesium level | Office | 2023 | 222 | 338 | $13,588 | $2,203 | 16.2% |
| 84550 | Uric acid level, blood | Office | 2023 | 355 | 431 | $11,689 | $1,893 | 16.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 419 | 533 | $7,196 | $1,161 | 16.1% |
About Dr. Cameron Golightly, DO
Dr. Cameron Golightly, DO is a Nephrology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2016. The National Provider Identifier (NPI) number assigned to this provider is 1821442682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cameron Golightly, DO has received a total of $1,665 in payments from pharmaceutical and medical device companies, with $705.40 received in 2024. These payments were reported across 106 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,655).
As a Medicare-enrolled provider, Golightly has provided services to 16,333 Medicare beneficiaries, totaling 28,232 services with total Medicare billing of $772,694. Data is available for 3 years (2021–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Student in an Organized Health Care Education/Training Program, Nephrology
- Location Chattanooga, TN
- Active Since 04/19/2016
- Last Updated 08/11/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1821442682
Products in Payments
- RAYALDEE (Drug) $247.07
- JYNARQUE (Drug) $238.63
- FARXIGA (Drug) $183.95
- Kerendia (Drug) $112.65
- JESDUVROQ (Drug) $95.86
- Parsabiv (Drug) $89.55
- ACTHAR (Biological) $79.95
- TAVNEOS (Drug) $66.04
- TARPEYO (Drug) $62.66
- LUPKYNIS (Drug) $47.55
- KRYSTEXXA (Biological) $42.48
- Fabhalta (Drug) $41.06
- BENLYSTA (Biological) $30.98
- Veltassa (Drug) $23.52
- Auryxia (Drug) $21.73
- FABRAZYME (Biological) $20.95
- ONPATTRO (Drug) $19.01
- KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) $18.40
- JARDIANCE (Drug) $15.02
- LOKELMA (Drug) $14.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Chattanooga
Rohit Gupta, M.d, M.D
Nephrology — Payments: $10,529
Nephrology $10,529
Hans Yehnert, Md, MD
Nephrology — Payments: $5,326
Nephrology $5,326
Nilesh Patel, M.d, M.D
Nephrology — Payments: $3,184
Nephrology $3,184
John Mccarley, M.d, M.D
Nephrology — Payments: $2,939
Nephrology $2,939
Brant Holt, Md, MD
Nephrology — Payments: $2,929
Nephrology $2,929
Mandeep Grewal, Md, MD
Nephrology — Payments: $2,449
Nephrology $2,449